Passive immunotherapy for COVID-19: the long and the short of it.
Journal articles
- Editorial
Mourad, A; Holland, TL
Published in: Clin Microbiol Infect
April 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Microbiol Infect
DOI
EISSN
1469-0691
Publication Date
April 2026
Volume
32
Issue
4
Start / End Page
525 / 526
Location
England
Related Subject Headings
- Microbiology
- 3207 Medical microbiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Mourad, A., & Holland, T. L. (2026). Passive immunotherapy for COVID-19: the long and the short of it. Clin Microbiol Infect, 32(4), 525–526. https://doi.org/10.1016/j.cmi.2026.01.020
Mourad, Ahmad, and Thomas L. Holland. “Passive immunotherapy for COVID-19: the long and the short of it.” Clin Microbiol Infect 32, no. 4 (April 2026): 525–26. https://doi.org/10.1016/j.cmi.2026.01.020.
Mourad A, Holland TL. Passive immunotherapy for COVID-19: the long and the short of it. Clin Microbiol Infect. 2026 Apr;32(4):525–6.
Mourad, Ahmad, and Thomas L. Holland. “Passive immunotherapy for COVID-19: the long and the short of it.” Clin Microbiol Infect, vol. 32, no. 4, Apr. 2026, pp. 525–26. Pubmed, doi:10.1016/j.cmi.2026.01.020.
Mourad A, Holland TL. Passive immunotherapy for COVID-19: the long and the short of it. Clin Microbiol Infect. 2026 Apr;32(4):525–526.
Published In
Clin Microbiol Infect
DOI
EISSN
1469-0691
Publication Date
April 2026
Volume
32
Issue
4
Start / End Page
525 / 526
Location
England
Related Subject Headings
- Microbiology
- 3207 Medical microbiology
- 3202 Clinical sciences